Publisher: First World Pharma

In the Media

AVITA Medical Announces FDA Approval of the RECELL System for the Treatment of Severe Burns in the U.S.

In the Media Icon

A global regenerative medicine company, today announced that the U.S. Food and Drug Administration (FDA) approved the Company’s Premarket Approval (PMA) application to market the RECELL® Autologous Cell Harvesting Device (RECELL® System) to treat severe thermal burns in patients 18 years and older. The RECELL System uses a small amount of a patient’s own skin… Read More